1. Home
  2. WB vs SPRC Comparison

WB vs SPRC Comparison

Compare WB & SPRC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Weibo Corporation

WB

Weibo Corporation

HOLD

Current Price

$9.58

Market Cap

2.5B

Sector

Technology

ML Signal

HOLD

Logo SciSparc Ltd.

SPRC

SciSparc Ltd.

HOLD

Current Price

$5.60

Market Cap

4.0M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
WB
SPRC
Founded
2009
2004
Country
China
Israel
Employees
N/A
N/A
Industry
Computer Software: Programming Data Processing
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.5B
4.0M
IPO Year
2014
2014

Fundamental Metrics

Financial Performance
Metric
WB
SPRC
Price
$9.58
$5.60
Analyst Decision
Strong Buy
Analyst Count
1
0
Target Price
$14.00
N/A
AVG Volume (30 Days)
912.6K
91.8K
Earning Date
01-01-0001
01-01-0001
Dividend Yield
16.98%
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$0.53
N/A
Revenue Next Year
$2.15
N/A
P/E Ratio
$5.66
N/A
Revenue Growth
N/A
N/A
52 Week Low
$7.10
$0.23
52 Week High
$12.96
$8.90

Technical Indicators

Market Signals
Indicator
WB
SPRC
Relative Strength Index (RSI) 32.16 94.09
Support Level $9.40 $1.52
Resistance Level $9.60 $6.36
Average True Range (ATR) 0.25 0.24
MACD -0.05 0.52
Stochastic Oscillator 6.42 89.39

Price Performance

Historical Comparison
WB
SPRC

About WB Weibo Corporation

Weibo Corp is a China-based company mainly engaged in the social media advertising business for people to create, discover and distribute content. The company's activities include Advertising and Marketing, which mainly provides a full range of advertising customization and marketing solutions. The Value-added Services mainly provide services such as membership services on social platforms, online games, live broadcasts, social e-commerce, and others. The Company's main product is the social platform Weibo.

About SPRC SciSparc Ltd.

SciSparc Ltd is a specialty clinical stage pharmaceutical company. It is engaged in developing several immunotherapy products and it owns patents in the immunotherapy field. It is focused on creating and enhancing a portfolio of technologies and assets based on cannabinoid pharmaceuticals. The company has two reportable segments; development of drugs based on cannabinoid molecules to be approved by an official regulatory authority (the company's operation); and online sales of a various range of hemp-based products including hemp gummies, hemp oil capsules, hemp gel, hemp cream, detox pills, height pills, antibacterial creams, and anti-aging creams, among other beauty and hair treatment products that are all manufactured in the United States.

Share on Social Networks: